Talzenna (Talazoparib Capsule) 1mg

Talzenna (talazoparib) 1mg capsules are a prescription oral therapy for certain breast cancers. This targeted treatment belongs to the PARP inhibitor class, designed to interfere with cancer cell growth. Talzenna capsules offer a convenient once-daily dosing option for eligible patients.

Strength

1mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna (talazoparib) is used to treat HER2-negative, BRCA-mutated locally advanced or metastatic breast cancer in adults. It is prescribed after prior chemotherapy or endocrine therapy, depending on specific clinical criteria. Talazoparib is also indicated for germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer in patients with hormone receptor-positive disease. Patients should consult their healthcare provider to determine if Talzenna is appropriate for their condition.

Side Effects

Talzenna capsules are taken orally and work by blocking PARP enzymes, which helps prevent cancer cells from repairing their DNA. This interference can slow or stop tumor growth in some patients. Common effects may include mild nausea, fatigue, or changes in blood cell counts. Individual responses vary, and not all patients experience these effects.

Precautions & Warnings

Store Talzenna capsules at room temperature away from moisture and heat. Keep the medication in its original packaging to protect it from light. Always handle with care and follow local guidelines for the disposal of unused or expired medicines. If you are pregnant, planning pregnancy, or breastfeeding, discuss the risks and benefits with your healthcare provider before using Talzenna.

Avoid Interactions

Talzenna may interact with strong CYP3A inhibitors or inducers, which can affect its levels in the body. Avoid grapefruit products while taking this medication, as they may increase the risk of side effects. Talk to your doctor about all prescription, over-the-counter, and herbal products you are using to minimize potential interactions.

Frequently Asked Questions

Talzenna is used to treat certain types of breast cancer in adults, specifically HER2-negative, BRCA-mutated locally advanced or metastatic breast cancer.

Store Talzenna capsules at room temperature, away from moisture and heat, and keep them in the original packaging.

Talzenna may interact with some medications, including strong CYP3A inhibitors or inducers. Always inform your healthcare provider about all medications you are taking.

Common effects may include mild nausea, fatigue, or changes in blood cell counts. Individual responses vary.

Talzenna may cause harm to an unborn baby. Discuss the risks and benefits with your healthcare provider if you are pregnant or planning pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.